Luoxin Pharmaceuticals Group Stock Co.,Ltd. (002793.SZ) disclosed its performance forecast for the first three quarters of 2025. The company expects net profit attributable to shareholders to reach 22.7 million yuan to 25.2 million yuan, successfully turning from losses to profitability. Net profit after deducting non-recurring gains and losses is projected to be between 4.7 million yuan and 5.9 million yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.